Gabriella Lewis

Gabriella Lewis (23C) is from San Francisco, California, majoring in political science and women, gender, and sexuality studies. Outside the Wheel, she is involved with the Residence Hall Association and theater at Emory. She also enjoys national parks, eating ramen and telling people she's from California.

Town Hall Reveals In-Person Fall Term Still Uncertain

Outgoing President Claire Sterk addresses an audience of more than 2,700 about the state of Emory and its future. At an April 24 online town hall, outgoing University President Claire E. Sterk and Interim Provost and Executive Vice President for Academic Affairs Jan Love did not provide definitive answers to the myriad questions surrounding the [...]

Read More

Emory Title IX Office Continuing Operations Remotely

The University’s transition to online learning has left lingering questions for some of Emory’s key resources, chief among them is the Office of Title IX. The transition has forced the office to operate remotely and prepare for full-scale remote hearings, according to Title IX Coordinator Yolanda Buckner. All current cases will remain open and continue [...]

Read More

6 Incidents of Zoombombing Reported at Emory

Emory faculty, staff and students have reported six “Zoombombing” incidents since the transition to remote learning on March 23, according to Enterprise Chief Information Officer and Senior Vice Provost for Library Services and Digital Scholarship Rich Mendola.  Zoombombings are “instances of uninvited guests crashing online Zoom meetings, classrooms and webinars in order to shout slurs [...]

Read More

Emory Apologizes to Students for Miscommunication Over Support Stipend, Grants Extra $1K

Interim Provost and Executive Vice President for Academic Affairs Jan Love apologized in an April 2 email to recipients of the Student Support Stipend for unclear communication about where the stipend came from. She announced that recipients would receive an additional $1,000 from the Emory Together Fund. Love previously stated in a March 17 University-wide [...]

Read More

Emory Coronavirus Treatment Submitted to FDA

Ayushi Agarwal, Managing Editor On Thursday, Drug Innovation Ventures at Emory (DRIVE) submitted an Investigational New Drug (IND) application to the Food and Drug Administration (FDA) for their experimental COVID-19 treatment, EIDD-2801.  EIDD-2801 is an antiviral compound that directly attacks coronaviruses in the lungs. The compound, a nucleoside analogue, deceives the virus into attaching and [...]

Read More